Search

Search results

432 results found

Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.

Publication: Journal Article

Zitomersky, Naamah, Lisa Chi, Enju Liu, Kurtis R Bray, Konstantinos Papamichael, Adam S Cheifetz, Scott B Snapper, Athos Bousvaros, and Jocelyn A Silvester. 2024. “Anti-Infliximab Antibodies and Low Infliximab Levels Correlate With Drug Discontinuation in Pediatric Inflammatory Bowel Disease.”. Journal of Pediatric Gastroenterology and Nutrition 78 (2): 261-71.

Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.

Publication: Journal Article

Dong, Jeffrey, Hyder Said, Samuel J Miller, Hannah K Systrom, and Joseph D Feuerstein. 2024. “Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.”. Journal of Clinical Gastroenterology 58 (8): 805-9.

Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.

Publication: Journal Article

Feld, Lauren D, Amy S Oxentenko, Dawn Sears, Aline Charabaty, Loren G Rabinowitz, and Julie K Silver. 2023. “Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2709-15.

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.

Publication: Journal Article

Roblin, Xavier, Gérard Duru, Konstantinos Papamichael, Adam S Cheifetz, Sandy Kwiatek, Anne-Emmanuelle Berger, Mathilde Barrau, Louis Waeckel, Stéphane Nancey, and Stephane Paul. 2023. “Development of Antibodies to Ustekinumab Is Associated With Loss of Response in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 12 (10).

Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.

Publication: Journal Article

Shah, Ishani, Andy Silva-Santisteban, Katharine A Germansky, Arvind Trindade, Kara L Raphael, Vladimir Kushnir, Rishi Pawa, et al. 2023. “Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.”. The American Journal of Gastroenterology 118 (9): 1664-70.

Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a "smart" solution?

Publication: Journal Article

Hasan, Syed S, Sarah Ballou, Laurie Keefer, and Dipesh H Vasant. 2023. “Improving Access to Gut-Directed Hypnotherapy for Irritable Bowel Syndrome in the Digital Therapeutics’ Era: Are Mobile Applications a ‘smart’ Solution?”. Neurogastroenterology and Motility 35 (4): e14554.

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.

Publication: Journal Article

Johnson, Amanda M, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Vipul Jairath, Neeraj Narula, et al. 2023. “The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn’s Disease: Results From the SUCCESS Consortium.”. The American Journal of Gastroenterology 118 (2): 317-28.

Doctors Speak: A Qualitative Study of Physicians' Prescribing of Antidepressants in Functional Bowel Disorders.

Publication: Journal Article

Ongaro, Giulio, Sarah Ballou, Tobias Kube, Julia Haas, and Ted J Kaptchuk. 2023. “Doctors Speak: A Qualitative Study of Physicians’ Prescribing of Antidepressants in Functional Bowel Disorders.”. Culture, Medicine and Psychiatry 47 (3): 669-83.

Mostafa Soliman, M.D.

Person: Postdoctoral Research Fellow

Mostafa Soliman is a Research Fellow at Beth Israel Deaconess Medical Center and Harvard Medical School. His research focuses on improving outcomes in inflammatory bowel disease, gastroenterology, and oncology through clinical trials, translational studies, and data-driven approaches. He earned his...

Fellowship and Education

Page